|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07F 9/24 | (2006.01) |
| A61P 25/28 | (2006.01) | ||
| A61K 31/661 | (2006.01) |
| (11) | Number of the document | 3112372 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16001739.8 |
| Date of filing the European patent application | 2013-04-26 | |
| (97) | Date of publication of the European application | 2017-01-04 |
| (45) | Date of publication and mention of the grant of the patent | 2018-11-07 |
| (46) | Date of publication of the claims translation | 2019-01-10 |
| (30) | Number | Date | Country code |
| 201261639602 P | 2012-04-27 | US |
| (72) |
Vaino, Andrew, US
Biestek, Marek, US
Shkreli, Martin, US
|
| (73) |
Retrophin, Inc.,
3721 Valley Centre Drive, Suite 200, San Diego, CA 92130,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Pantotenato dariniai, skirti neurologinių sutrikimų gydymui |
| PANTOTHENATE DERIVATIVES FOR THE TREATMENT OF NEUROLOGIC DISORDERS |
| Payment date | Validity (years) | Amount | |
| 2019-04-02 | 7 | 162.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2020-04-26 |